PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,987 | -23.8% | 10,658 | -0.5% | 0.01% | -25.0% |
| Q2 2023 | $429,150 | +0.4% | 10,710 | +2.3% | 0.01% | 0.0% |
| Q1 2023 | $427,281 | +9.5% | 10,470 | +3.6% | 0.01% | 0.0% |
| Q4 2022 | $390,347 | -30.5% | 10,110 | -4.3% | 0.01% | -33.3% |
| Q3 2022 | $562,000 | -10.2% | 10,561 | -1.7% | 0.01% | -7.7% |
| Q2 2022 | $626,000 | -21.1% | 10,742 | -63.1% | 0.01% | 0.0% |
| Q1 2022 | $793,000 | +34.6% | 29,138 | +197.8% | 0.01% | +44.4% |
| Q4 2021 | $589,000 | +2.3% | 9,786 | -4.8% | 0.01% | 0.0% |
| Q3 2021 | $576,000 | -6.0% | 10,284 | +1.9% | 0.01% | 0.0% |
| Q2 2021 | $613,000 | -14.7% | 10,095 | -1.6% | 0.01% | -25.0% |
| Q1 2021 | $719,000 | +103.7% | 10,261 | +74.1% | 0.01% | +100.0% |
| Q4 2020 | $353,000 | -51.0% | 5,893 | -50.8% | 0.01% | -57.1% |
| Q3 2020 | $720,000 | +11.3% | 11,968 | -2.9% | 0.01% | 0.0% |
| Q2 2020 | $647,000 | +48.4% | 12,322 | -5.2% | 0.01% | +16.7% |
| Q1 2020 | $436,000 | +18.8% | 13,004 | +60.5% | 0.01% | +50.0% |
| Q4 2019 | $367,000 | -39.5% | 8,104 | -49.1% | 0.01% | -38.5% |
| Q3 2019 | $607,000 | -10.9% | 15,935 | +1.8% | 0.01% | -13.3% |
| Q2 2019 | $681,000 | +13.3% | 15,648 | -0.9% | 0.02% | +7.1% |
| Q1 2019 | $601,000 | -15.6% | 15,796 | -4.5% | 0.01% | -30.0% |
| Q4 2018 | $712,000 | -26.9% | 16,546 | -16.5% | 0.02% | -16.7% |
| Q3 2018 | $974,000 | -14.1% | 19,813 | -16.7% | 0.02% | -38.5% |
| Q2 2017 | $1,134,000 | +0.8% | 23,775 | -3.7% | 0.04% | -4.9% |
| Q1 2017 | $1,125,000 | +52.4% | 24,676 | +8.0% | 0.04% | +36.7% |
| Q4 2016 | $738,000 | -10.7% | 22,841 | -5.4% | 0.03% | -16.7% |
| Q3 2016 | $826,000 | +2.7% | 24,138 | +1.3% | 0.04% | 0.0% |
| Q2 2016 | $804,000 | -24.6% | 23,838 | +18.3% | 0.04% | -30.8% |
| Q1 2016 | $1,067,000 | -35.5% | 20,144 | -6.6% | 0.05% | -37.3% |
| Q4 2015 | $1,655,000 | +94.0% | 21,557 | +3.9% | 0.08% | +88.6% |
| Q3 2015 | $853,000 | -46.6% | 20,751 | -8.1% | 0.04% | -38.9% |
| Q2 2015 | $1,597,000 | -9.6% | 22,575 | +13.5% | 0.07% | -10.0% |
| Q1 2015 | $1,767,000 | +3.3% | 19,885 | +3.0% | 0.08% | -1.2% |
| Q4 2014 | $1,711,000 | -5.0% | 19,299 | +3.8% | 0.08% | -9.0% |
| Q3 2014 | $1,802,000 | +18.7% | 18,588 | +12.5% | 0.09% | +17.1% |
| Q2 2014 | $1,518,000 | +23.9% | 16,524 | -5.6% | 0.08% | +13.4% |
| Q1 2014 | $1,225,000 | +34.0% | 17,505 | +10.2% | 0.07% | +48.9% |
| Q4 2013 | $914,000 | +39.5% | 15,890 | +16.6% | 0.04% | +28.6% |
| Q3 2013 | $655,000 | +53.8% | 13,630 | -7.2% | 0.04% | +45.8% |
| Q2 2013 | $426,000 | – | 14,680 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |